Related Experiment Videos
Pharmaceuticals and medicare managed care: pharmacoeconomic considerations
1Center for Health Outcomes and PharmacoEconomic Research, and Department of Pharmacy Practice and Science, College of Pharmacy, The University of Arizona, Tucson 85721-0207, USA.
Clinical Therapeutics
|January 23, 1999
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effects of exercise intensity on gut microbiome composition and function in people with type 2 diabetes.
European journal of sport science·2022
AXILOSPHAERA AND HETEROTETRACYSTIS, NEW CHLOROSPHAERACEAN GENERA FROM TENNESSEE SOIL(1) (2).
Journal of phycology·2016
Severe life-threatening Ehrlichia chaffeensis infections transmitted through solid organ transplantation.
Transplant infectious disease : an official journal of the Transplantation Society·2013
The patient-reported outcome (PRO) consortium: filling measurement gaps for PRO end points to support labeling claims.
Clinical pharmacology and therapeutics·2011
Equivalence of Chinese and US-English versions of the SF-36 health survey.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2003
Barriers to use of electronic adherence monitoring in an HIV clinic.
The Annals of pharmacotherapy·2001
Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.
Canadian journal of kidney health and disease·2026
Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.
Therapeutic advances in neurological disorders·2026